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The presequence of Euglena LHCPII, a cytoplasmically synthesized
chloroplast protein, contains a functional endoplasmic
reticulum-targeting domain
(nilcrosomal processing/signal peptide/polyprotein)

RAM KISHORE*, UMESH S. MUCHHAL, AND STEVEN D. SCHWARTZBACHt
School of Biological Sciences, University of Nebraska, Lincoln, NE 68588

Communicated by Myron K. Brakke, September 20, 1993 (received for review May 5, 1993)

ABSTRACT
The precursor to the Euglena light-harvesting chlorophyll a/b-binding protein of photosystem II
(pLHCPII) is unique; it is a polyprotein, synthesized on
membrane-bound ribosomes and transported to the Golgi
apparatus prior to chloroplast localization. A cDNA corresponding to the 5' end of LHCPII mRNA has been isolated and
sequenced. The deduced amino acid sequence of this cDNA
indicates that Euglena pLHCPII contains a 141-amino acid
N-terminal extension. The N-terminal extension contains three
hydrophobic domains and a potential signal peptidase cleavage
site at amino acid 35. Cotranslational processing by canine
microsomes removed approximately 35 amino acids from an in
vitro synthesized 33-kDa pLHCPII composed of a 141-amino
acid N-terminal extension and a 180-amino acid partial LHCPU unit truncated at the beginning of the third membranespanning hydrophobic domain. Processed pLHCPII was degraded by exogenous protease, indicating that it had not been
translocated to the microsomal lumen. Extraction with 0.1 M
Na2CO3, pH 11.5, did not remove the processed pLHCPII from
the microsomal membrane. A stop-transfer membrane anchor
sequence appears to anchor the nascent protein within the
membrane, preventing translocation into the lumen. Taken
together, these results provide biochemical evidence for a
functional cleaved signal sequence within the N-terminal extension of a Euglena cytoplasmically synthesized chloroplastlocalized protein.

The light-harvesting chlorophyll a/b-binding proteins of photosystem II (LHCPII) are a group of highly conserved 25- to
28-kDa proteins encoded by a nuclear multigene family
composed of 3-20 members, depending upon the organism
studied (1). Differences in gene structure and amino acid
composition at 14 positions allow LHCPIIs to be classified
into three types (2). What if any functional differences exist
between LHCPII types remain unclear.
Chloroplast proteins are synthesized as precursors containing an N-terminal extension, the transit peptide, which
contains the information required for the posttranslational
uptake and proteolytic processing of the precursor by the
chloroplast (3, 4). The precursor of LHCPII, pLHCPII,
typically contains a 29- to 36-amino acid transit peptide (4).
The pLHCPII transit peptide is required for chloroplast
localization, while insertion of pLHCPII into the thylakoid
membrane appears to utilize targeting signals contained
within the mature protein (5-7). Euglena pLHCPIIs are
unique polyproteins encoded by 6.6- and 9.5-kb mRNAs (8).
A Euglena pLHCPII genomic clone (GC18) encodes five
mature LHCPIIs separated by decapeptide linkers (9, 10).
The LHCPIIs can be divided into three groups. There is
greater than 90% amino acid sequence identity within a group

and 50-70% identity between groups (9). Since GC18 comprises slightly more than half of the gene encoding the 6.6-kb
LHCPII mRNA (9), the complete Euglena pLHCPII polyprotein probably contains 8 or 9 LHCPIIs.
A number of differences have been found between the
synthesis of Euglena LHCPII and the synthesis of LHCPII in
all other organisms. The light-induced synthesis of Euglena
pLHCPII is regulated at the level of translational elongation
(11) rather than at transcription. The half-life of Euglena
pLHCPII is 20 min, in contrast to the extremely short half life
of pLHCPII in other plants and algae (8, 12). Euglena
pLHCPII is synthesized on membrane-bound ribosomes as
found for proteins transported into the endoplasmic reticulum (ER) rather than on free ribosomes as normally found for
cytoplasmically synthesized chloroplast proteins (4, 11). Immunogold electron microscopy localizes Euglena LHCPII to
the Golgi apparatus and chloroplast when LHCPII is being
synthesized, while at times when LHCPII is not being
synthesized, an immunoreaction is seen only in the chloroplast (10, 13). It thus appears that Euglena pLHCPII is
transported into the ER prior to chloroplast localization.
In contrast to post-translational transport of proteins into
chloroplasts, transport of proteins into the ER is cotranslational and dependent upon a 15- to 30-amino acid
N-terminal extension, the signal sequence (3). The signal
sequence is cleaved on the lumenal side of the ER membrane
(3, 14). Signal peptides differ in length and primary sequence
(3, 15). All identified signal peptides contain a positively
charged N-terminal region, a hydrophobic core, and a more
polar C-terminal region (3, 15). The signal peptidase cleavage
site can be predicted on the basis of the amino acid found at
the -1 and -3 positions (15, 16). The precursor to a Euglena
calcium-binding protein contains a typical eukaryotic threedomain signal peptide at its N terminus (17). This Euglena
precursor is cotranslationally processed by and translocated
into canine microsomes (17), demonstrating that canine microsomes can be used as an in vitro system for identifying
functional Euglena signal peptides.
The precursors to two Euglena cytoplasmically synthesized chloroplast-localized proteins, the small subunit of
ribulose-1,5-bisphosphate carboxylase/oxygenase (SSU)
and porphobilinogen deaminase (PBGD), contain 134- and
139-amino acid N-terminal extensions (18, 19). The N-terminal extensions do not resemble chloroplast transit peptides,
but the N-terminal 35-40 amino acids constitute a signal
peptide domain with a potential signal peptidase cleavage site
Abbreviations: ER, endoplasmic reticulum; Lac, 3-lactamase;
LHCPII, light-harvesting chlorophyll a/b-binding proteins of photosystem II; pLHCPII, precursor to LHCPII (other precursors are
named similarly); PBGD, porphobilinogen deaminase; SSU, ribulose-1,5-bisphosphate carboxylase/oxygenase small subunit.
*Present address: Department of Cell Biology and Anatomy, New
York Medical College, Valhalla, NY 10595.
tTo whom reprint requests should be addressed.
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FIG. 1. Comparison of the deduced amino acid sequence of the N-terminal extension of Euglena LHCPII (LHCP), Euglena SSU (18), and
Euglena PBGD (19) precursors. Hydrophobic domains (underlined), predicted N-terminal signal peptidase cleavage site (*), hydroxylated amino
acids (o), charged amino acids (+, -), and the start of the mature protein (boldface) are indicated.

(18-20). The precursor ofPBGD, pPBGD, was not processed
by or transported into canine microsomes, suggesting that the
signal peptide domain and signal peptidase cleavage site are
nonfunctional (20). This paper characterizes the N-terminal
extension of Euglena pLHCPII.* As found for pPBGD and
pSSU, pLHCPII contains a 141-amino acid N-terminal extension having a signal-peptide-like domain within the first 35
amino acids. Euglena pLHCPII was cotranslationally processed by and inserted into canine microsomes. For the first
time that we are aware of, biochemical evidence has been
obtained demonstrating that a Euglena cytoplasmically synthesized chloroplast-localized protein contains a functional
signal peptide. A brief report of this work has appeared (21).

MATERIALS AND METHODS
Construction of Clones Encoding Truncated LHCPII Polyproteins. NLH1, a cDNA clone complementary to the 5' end
of Euglena pLHCPII mRNA, was isolated by reverse transcriptase-PCR using two nested 3' primers and a 5' primer
complementary to the trans-spliced sequence found at the 5'
end of most Euglena mRNAs (22). First-strand cDNA was
synthesized by using the oligonucleotide 5'-CATGGCCAGGCGGCCGTTCTT-3', which corresponds to a conserved
region of Euglena LHCPII (9). Second-stand synthesis and
amplification utilized the oligonucleotide 5'-CGAGCTCGAGTGTCVTTTTTTTTCG-3', corresponding to the 5'
consensus trans-spliced sequence (22), and the oligonucleotide 5'-CCGTTCTTCACCTCCTTCACCTT-3', corresponding to a nested conserved region within Euglena LHCPII (9).
cDNA was synthesized from 10 pg of total RNA by using
Superscript reverse transcriptase (GIBCO/BRL) as described by the supplier. PCR amplification was performed by
using Pfu DNA polymerase (Stratagene) as described by the
supplier for 30 cycles of 1 min at 95°C, 30 sec at 60°C, and 3
min (last cycle 15 min) at 75°C. The PCR product was gel
purified and subcloned as a blunt-ended insert into the
polylinker of the vector pBluescript II KS (+) (Stratagene),
using standard protocols (23). The EcoRI-Xba I fragment of
psAB80XD/4 (a gift of Kenneth Cline, University of Florida,
Gainesville) encoding pea pLHCPII (7) was also subcloned in
the polylinker of the vector pBluescript II KS (+). The
transcript encoding Escherichia coli j-lactamase was obtained from Promega. DNA sequences were determined as
described previously (9) and analyzed with the University of
Wisconsin Genetic Computer Group DNA sequence analysis
software (24).
In Vitro Processing Experiments. Capped transcripts were
synthesized by using T7 RNA polymerase (Promega) as
described by the supplier. Transcripts (0.1 ug/25-pI reaction
mixture) were translated for 60 min in a nuclease-treated
rabbit reticulocyte lysate (Promega) containing [35S]methionine in the presence or absence of 3.6 equivalents of canine

tThe sequence from which the amino acid sequence reported in this

paper has been deduced has been deposited in the GenBank data
base (accession no. U03392).

pancreatic microsomal membranes (Promega) as described
by the supplier. Translation was terminated by the addition
of 0.1 vol of a solution containing 0.12 M methionine and 0.3
mM cycloheximide. Protease protection assays were performed by incubating the translation mix for 1 h on ice with
proteinase K at 0.1 mg/ml and 10 mM CaCl2 in the presence
or absence of 0.5% Triton X-100 (25). Microsomal membranes were extracted with Na2CO3 (26) by incubation for 30
min on ice with 100 mM Na2CO3, pH 11.5, and 3 equivalents
of microsomal membranes. The Na2CO3-extracted membranes were recovered by centrifugation for 15 min at 150,000
x g. Microsomal membranes were washed with potassium
acetate (26) by adding an equal volume of 1 M potassium
acetate and 3 equivalents of microsomal membranes to the
translation mixture, layering 20 y4 of membranes over a
100-,Al cushion of 0.5 M sucrose/0.5 M potassium acetate/2
mM magnesium acetate and recovering the membranes by
centrifugation for 10 min at 150,000 x g. All centrifugations
were performed at 0-4°C. Translation products were immunoprecipitated with anti-LHCPII, proteins were separated on
SDS/8-12% polyacrylamide gels, and [35S]methioninelabeled proteins were visualized by fluorography as described previously (8). Densitometric analysis of the fluorographs was performed with a Visage 60 image analyzer
(Biolmage, Ann Arbor, MI) using whole band analysis software. The amount of protein recovered in the membrane
pellet is expressed as a fraction of the total protein recovered
in the pellet and supernatant fractions.

RESULTS
A cDNA clone, NLH1, corresponding to the 5' end of the
Euglena 6.6-kb LHCPII mRNA was obtained by reverse
transcriptase-PCR. NLH1 encodes a 33-kDa protein composed of a 141-amino acid N-terminal extension (Fig. 1) and
a 180-amino acid truncated LHCPII unit ending just prior to
the third membrane-spanning hydrophobic domain (9). The
N-terminal extension contains three hydrophobic domains.
Amino acid 35 is the predicted signal peptidase cleavage site
of a potential signal peptide (15, 16). The decapeptide linking
LHCPII units within the polyprotein precursor has the consensus sequence XMXAXXGXKX (9, 10). The four conserved amino acids are probably processing protease recognition sequences. The N-terminal extension ends in the
peptide ATMATSGKKS (Fig. 1). The conserved C-terminal
linker sequence (GXKX) is present at the presequencemature protein junction but the conserved N-terminal linker
sequence (XMXA) is missing. This suggests that the C
terminus of the decapeptide linker and the N-terminal extension are cleaved by the same processing protease.
Known chloroplast transit peptides are enriched in hydroxylated amino acids and have few acidic amino acids, and their
C-terminal domain has a high potential for forming an amphiphilic ,B-strand (4). The Euglena pLHCPII N-terminal
extension is enriched in hydroxylated amino acids. However,
there are a large number of acidic amino acids (Fig. 1) and an
amphiphilic j-strand-forming domain is absent. The overall
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structure of the N-terminal extension is not indicative of a
chloroplast transit peptide.
The N-terminal extensions of Euglena pLHCPII, pSSU
(18), and pPBGD (19) are significantly longer than the 20amino acid signal peptide found on the precursor to a Euglena
ER-targeted calcium-binding protein (17). Alignment at the
N-terminal methionine indicates little sequence homology
between the three chloroplast presequences, although they
do share a number of structural similarities (Fig. 1). Each
presequence contains a potential signal peptidase cleavage
site 32 (SSU, PBGD) to 35 (LHCPII) amino acids from the N
terminus (Fig. 1). The regions flanking the second hydrophobic domain are enriched in charged amino acids. The second
hydrophobic domain of the pLHCPII presequence is a potential signal peptide (16) and it is large enough to span the
membrane (19 amino acids), suggesting that it could function
as a stop-transfer membrane anchor sequence. The corresponding hydrophobic domains in the SSU and PBGD presequences are not sufficiently large to function as membranespanning domains (Fig. 1). Another difference is the absence
of a third hydrophobic domain in the SSU and PBGD
presequences (Fig. 1).
Canine microsomes provide an in vitro system for identification of functional signal peptides (25). The small size of
the pLHCPII N-terminal extension (14 kDa) relative to the
large size of the pLHCPII polyprotein (207 kDa) would make
the molecular mass change due to presequence removal
difficult to detect on SDS gels. To overcome this problem, in
vitro processing studies utilized the truncated pLHCPII
encoded by the cDNA clone NLH1.
In vitro transcripts were prepared from NLH1 and translated in a nuclease-treated rabbit reticulocyte lysate, and the
products were immunoprecipitated with anti-LHCPII to
eliminate endogenous reticulocyte translation products. A
full-length 33-kDa protein, p-NLH1, is the major NLH1
mRNA translation product synthesized in the absence of
microsomes (Fig. 2A, lane 1) and when canine microsomes
were added after termination of translation (Fig. 2A, lane 5).
A 30-kDa protein, i-NLH1, is the major NLH1 translation
product synthesized when canine microsomes were present
A Euglena LHCPII (NLH1)
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FIG. 2. Microsomal processing of a truncated Euglena pLHCPII
and E. coli 3-lactamase. mRNA encoding a truncated Euglena
pLHCPII transcribed from clone NLH1 (A) or E. coli p(-lactamase
mRNA (B) was translated in the absence (lane 1) or presence (lanes
2-4) of canine microsomes. Translation was stopped and the translation mixtures were incubated with proteinase K (lane 3), proteinase
K and Triton X-100 (lane 4), or microsomal membranes (lane 5).
Translation products were immunoprecipitated with anti-LHCPII in
A and in both cases were separated by SDS gel electrophoresis and
visualized by fluorography. p-NLH1 and p-Lac, full-length translation products; i-NLH1 and Lac, processed translation products.
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during translation (Fig. 2A, lane 2). The cotranslational
conversion of p-NLH1 to i-NLH1 through removal of an
approximately 3-kDa peptide demonstrates the presence of a
functional cleaved signal peptide. The procedure of von
Heijne (15, 16) predicts a signal peptidase cleavage site 35
amino acids from the N terminus.
Signal peptide removal occurs on the lumenal face of the
microsomal membrane (14). The cotranslational conversion
of p-NLH1 to i-NLH1 demonstrates insertion of the nascent
protein into the microsomal membrane and initiation of
translocation into the lumen. In the absence of a membrane
anchor stop-transfer sequence (3), i-NLH1 would be translocated into the microsomal lumen and the microsomal
membrane would protect i-NLH1 from degradation by exogenous protease (25). To determine whether i-NLH1 was
translocated through the microsomal membrane, microsomecontaining translation mixtures were incubated with proteinase K at the completion of translation. As expected, the
unprocessed translation product, p-NLH1, was completely
degraded (Fig. 2A, lanes 3 and 4). Unexpectedly, the cotranslationally processed translation product, i-NLH1 was
also completely degraded (Fig. 2A, lanes 3 and 4). This
suggests that translocation into the microsomal lumen was
prevented by a membrane anchor stop-transfer sequence, the
microsomal membrane preparation was not translocation
competent, or the microsomal membranes were not intact
and thus were unable to protect the protein from exogenous
protease.
The precursor to E. coli ,B-lactamase (p-Lac) is known to
be cotranslationally processed by and transported into canine
microsomes, providing a positive control for assessing the
intactness and translocation competence of the canine microsomal preparation. p-Lac was synthesized in vitro and
cotranslationally processed to ,B-lactamase (Lac) by the canine microsomal membrane preparation utilized for p-NLH1
processing (Fig. 2B, lanes 1 and 2). Lac was protected from
proteinase K degradation in the absence but not in the
presence of detergent (Fig. 2B, lanes 3 and 4), confirming the
intactness and translocation competence of the microsomal
membrane preparation.
Since the microsomal membranes were intact and translocation competent, the protease sensitivity of i-NLH1 suggests that it was inserted into but not fully translocated
through the microsomal membrane. Depending on the number of start- and stop-transfer sequences, either a large
C-terminal tail or multiple loops may be exposed on the outer
surface of the membrane (3), resulting in protease-protected
fragments which are too small to be resolved on the gels used.
Na2CO3 extraction converts microsomal vesicles into open
membrane sheets, releasing lumenal and peripheral proteins
while integral membrane proteins remain associated with the
membrane (27). Extraction with 0.5 M potassium acetate
releases many but not all peripheral proteins, while lumenal
proteins are not released (25). To determine if i-NLH1 is an
integral membrane protein, NLH1 mRNA was translated in
the presence of canine microsomes, membranes were extracted with potassium acetate or Na2CO3, and the extracted
membranes were recovered by centrifugation.
Canine microsomes cotranslationally processed p-NLH1
to i-NLH1 (Fig. 3A, lanes 1 and 2). All of the p-NLH1 and
i-NLH1 were recovered in the membrane pellet after potassium acetate extraction (Fig. 3A, lanes 5 and 6). On the other
hand, a large amount of the i-NLH1 but only a small amount
of the p-NLH1 pelleted with Na2CO3-extracted membranes
(Fig. 3A, lanes 3 and 4). Densitometric analysis of the
fluorograph indicated that 70% of the i-NLH1 and only 8% of
the p-NLH1 were recovered in the membrane pellet after
Na2CO3 extraction. The Na2CO3-resistant association of
i-NLH1 with microsomes suggests that it is an integral
membrane protein.
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FIG. 3. Microsomal processing and intramicrosomal localization
of a truncated Euglena pLHCPII, pea pLHCPII, and E. coli p,&
lactamase. mRNA encoding a truncated Euglena pLHCPII transcribed from clone NLH1 (A), pea LHCPII mnRNA (B), or E. coli
pp-lactamase mRNA (C) was translated in the presence (lanes 2-6)
or absence (lane 1) of canine microsomes. Translation was stopped,
and the membranes were incubated with 0.1 M Na2CO3 (CO3) or 0.5
M potassium acetate (Ac) and separated into pellet (P) and supernatant fractions (S). Translation products were immunoprecipitated
with anti-LHCPII in A and in all three cases were separated by SDS
gel electrophoresis and visualized by fluorography. p-NLH1,
pLHCP, and p-Lac, full-length translation products; i-NLH1 and
Lac, processed translation products.

The LHCPII portion of p-NLH1 and i-NLH1 is 65%
identical to higher plant LHCPIIs and contains two of the
three hydrophobic membrane-spanning domains that mediate the post-translational insertion of LHCPII into the thylakoid membrane (5-7, 9). Nonspecific alkali-resistant interactions between LHCPII and a variety of membranes, including microsomal membranes, have been reported (6). The
Na2CO3-resistant i-NLH1 membrane association could thus
be due to a nonspecific interaction between the hydrophobic
domains of LHCPII and the Na2CO3-disrupted membranes.
Alternatively, the Na2CO3 extraction conditions used may
not fully disrupt the membrane, causing retention or trapping
of lumenal and other soluble proteins. As positive controls
for the release of nonspecifically bound hydrophobic proteins
and trapping of soluble lumenal proteins, the cotranslational
association of pea pLHCPII and E. coli ,B-lactamase with
canine microsomes was studied.
p-Lac synthesized in vitro by the reticulocyte lysate was
cotranslationally processed to Lac (Fig. 3C, lanes 1 and 2).
As expected for a protein translocated to the microsomal
lumen, all of the Lac was recovered in the microsomal pellet
after potassium acetate extraction (Fig. 3C, lanes 5 and 6).
Na2CO3 extraction released all of the Lac to the membranefree supernatant (Fig. 3C, lanes 3 and 4). The failure to detect
Lac in the membrane pellet demonstrates that the microsomal vesicles were fully disrupted and that nonmembrane
proteins were not trapped and recovered in the membrane
pellet.
The full-length pea p-LHCPII synthesized in vitro by the
reticulocyte lysate (p-LHCP) was not processed by canine
microsomes (Fig. 3B, lanes 1 and 2). p-LHCP was equally

distributed between the potassium acetate-extracted microsomal membrane pellet and supernatant (Fig. 3B, lanes 5
and 6). Na2CO3 extraction removed p-LHCP from the microsomal membranes (Fig. 3B, lanes 3 and 4). Densitometric
analysis of the fluorographs indicates that only 28% of
p-LHCP was recovered in the microsomal pellet after
Na2CO3 extraction. Since studies with Lac failed to find
evidence for nonspecific trapping of proteins within the
Na2CO3-extracted membrane pellet, the Na2CO3-resistant
association of p-LHCP with microsomes is not an artifact
produced by incomplete vesicle disruption or protein trapping. It appears that, as reported by others (6), LHCPII
spontaneously forms nonspecific alkali-resistant associations
with microsomal membranes. The propensity of LHCPII to
form nonspecific alkali-resistant associations with microsomes does not explain the large amount of i-NLH1 (70%)
relative to the small amount of p-NLH1 (8%) and pea
p-LHCP (28%) recovered with Na2CO3-extracted membranes. The differential recovery is most likely due to the fact
that i-NLH1 has been inserted and anchored within the
membrane while p-NLH1 and pea p-LHCPII form nonspecific hydrophobic associations.

DISCUSSION
Euglena chloroplasts are surrounded by three membranes
rather than two as found in higher plants and green algae (28).
The origin of this third chloroplast membrane, the perichloroplast membrane, is controversial. It has been postulated
that the perichloroplast membrane evolved from the plasma
membrane of the original photosynthetic symbiont, that it
evolved from a phagocytic vacuole membrane, or that it is
part of the ER (28). Regardless of the origin of the perichloroplast membrane, Euglena cytoplasmically synthesized
chloroplast-localized proteins must contain targeting information for transit through a membrane closely related to ER
membranes in addition to information for transit through
chloroplast membranes. Studies of a recently characterized
Euglena ER-targeted protein identified a typical eukaryotic
signal peptide at the N terminus (17). This protein was
cotranslationally processed and translocated into canine microsomes, demonstrating that ER targeting in Euglena is not
different from targeting in other organisms (17).
A 33-kDa protein, p-NLH1, composed of the Euglena
pLHCPII N-terminal extension and a truncated LHCPII, was
cotranslationally processed in vitro by canine microsomes.
Signal peptidase resides on the lumenal side of the microsomal membrane (14). Cotranslational removal of a 3-kDa
peptide demonstrates that the Euglena pLHCPII N-terminal
extension contains a functional signal peptide domain that
can insert the protein into the membrane and initiate translocation into the lumen. The functional signal peptidase
cleavage site, 35 amino acids from the N terminus, is at the
position predicted by the method of von Heinje (15, 16).
The processed protein i-NLH1 was not protected from
degradation by exogenous protease, indicating that it was not
fully translocated into the lumen. All of the unprocessed
p-NLH1, all of the soluble lumen-resident protein (-lactamase, and 72% of the pea p-LHCP containing the three
membrane-insertion domains found in Euglena LHCPII were
released from the microsomal membrane by Na2CO3 extraction. On the other hand, only 30% of the i-NLH1 was
removed by Na2CO3 extraction. Taken together with the
cotranslational conversion of p-NLH1 to i-NLH1, the
Na2CO3-resistant association of i-NLH1 with microsomes
suggests that i-NLH1 is inserted into the membrane and
anchored within the lipid bilayer by a membrane anchor
stop-transfer sequence.
Euglena pLHCPII is synthesized on membrane-bound

polysomes (11) and transported to the ER and Golgi appa-
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ratus prior to chloroplast localization (10, 13). Two other
Euglena cytoplasmically synthesized chloroplast proteins,
PBGD (20, 29) and SSU (13), are transported directly into the
chloroplast. The N-terminal extensions of pPBGD and pSSU
show no sequence identity to the pLHCPII extension. All
three presequences are, however, extremely large (134-141
amino acids) and contain a signal peptide domain with
predicted signal peptidase cleavage sites 32-35 amino acids
from the N terminus. The signal peptide domain of the
chloroplast presequences is larger than but structurally similar to most eukaryotic signal peptides (3, 16), including the
signal peptide of a Euglena ER-targeted protein (17).
Attempts to directly demonstrate cotranslational processing and import of pPBGD by canine microsomes were
unsuccessful (20). E. coli signal peptidase did, however,
remove approximately 35 amino acids from pPBGD, suggesting the presence of a functional signal sequence (20). Although the complete 139-amino acid pPBGD presequence is
removed in one step during post-translational import into
isolated Euglena chloroplasts, import is abolished by removal of the first 30 amino acids, which compose the signal
peptide domain of the presequence (20). This suggests that
import of pPBGD into Euglena chloroplasts is initiated by a
prokaryotic signal peptide domain which is nonfunctional in
a eukaryotic, canine microsome, processing system.
In vitro chloroplast import studies with pPBGD (20) and
our studies of microsomal processing of pLHCPII suggest a
bipartite structure for the N-terminal extension found on
Euglena cytoplasmically synthesized chloroplast proteins. A
signal peptide domain which may include a signal peptidase
cleavage site appears to initiate translocation through the
ER-like perichloroplast membrane. The remainder of the
presequence appears to function as a chloroplast targeting
sequence initiating translocation through the two chloroplast
membranes. This bipartite structure is analogous to but
functionally the reverse of the bipartite presequence of
thylakoid lumen proteins, where the N-terminal domain
contains information for translocation through the chloroplast envelope membranes, while the C-terminal domain is a
signal-peptide-like targeting signal for transport through the
thylakoid membrane into the lumen (4).
In vitro processing studies demonstrated that processed
pLHCPII was anchored within the microsomal membrane
with one or more segments exposed on the outer, proteaseaccessible, cytoplasmic membrane face. A 19-amino acid
hydrophobic domain is present in the chloroplast targeting
portion of the bipartite pLHCPII N-terminal extension and
probably functions as a membrane anchor stop-transfer sequence. This stop-transfer membrane anchor domain found
in the pLHCPII presequence is not present in the pPBGD and
pSSU presequences. The presence of a stop-transfer membrane anchor sequence may explain the initial sorting of
Euglena pLHCPII to the Golgi apparatus (10, 13), and
pPBGD (20, 29) and pSSU (13) directly to the chloroplast.
The pLHCPII stop-transfer sequence would prevent translocation of the chloroplast targeting presequence domain
through the perichloroplast membrane. The chloroplasttargeting domain would remain on the cytoplasmic side of the
perichloroplast membrane, unable to initiate translocation
into the chloroplast. Membrane-anchored pLHCPII would
enter the default secretory pathway and be transported to the
Golgi apparatus and then through an uncharacterized pathway to the chloroplast. The absence of a stop-transfer
sequence would permit pPBGD and pSSU to be transported
through the perichloroplast membrane. The chloroplasttargeting presequence domain would now be able to initiate
import into the chloroplast.
Euglenoids are not the only algal group containing chloroplasts surrounded by more than two membranes. The
chloroplasts of dinoflagellates are surrounded by three mem-
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branes, while chloroplasts of diatoms, brown algae, chrysophytes, and a number of other algal types are surrounded by
four membranes (28). The precursors to the diatom counterpart of LHCPII, the fucoxanthin chlorophyll a/c-binding
proteins, do not contain a typical transit sequence (30, 31).
The Phaeodactylum fucoxanthin chlorophyll a/c-binding
protein presequences are shorter (31 amino acids) than the
Euglena presequences but, as found for Euglena, they have
the three-domain structure characteristic of a signal peptide
(30, 31). The Phaeodactylum presequence initiates cotranslational import into canine microsomes and is cleaved (31).
Cotranslational transport of chloroplast precursor proteins
into an ER-like compartment is thus not unique to Euglena
but appears to be a common mechanism for targeting proteins
to chloroplasts in photosynthetic organisms other than higher
plants and green algae. Euglena is, however, the only organism identified to date as having polyprotein precursors that
are transported to the Golgi apparatus prior to chloroplast
localization.
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